CEB6- THE IMPORTANCE OF COMPARABLE PATIENT POPULATIONS IN COST-EFFECTIVENESS ANALYSES- TOLTERODINE VERSUS OXYBUTININ XL FOR TREATING OVERACTIVE BLADDER
Mar 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70363-1
https://www.valueinhealthjournal.com/article/S1098-3015(11)70363-1/fulltext
Section Title :
Section Order :
215
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70363-1&doi=10.1016/S1098-3015(11)70363-1